title: Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.
abstract: Seasonal and pandemic influenza A virus (IAV) continues to be a public health threat. However, we lack a detailed and quantitative understanding of the immune response kinetics to IAV infection and which biological parameters most strongly influence infection outcomes. To address these issues, we use modeling approaches combined with experimental data to quantitatively investigate the innate and adaptive immune responses to primary IAV infection. Mathematical models were developed to describe the dynamic interactions between target (epithelial) cells, influenza virus, cytotoxic T lymphocytes (CTLs), and virus-specific IgG and IgM. IAV and immune kinetic parameters were estimated by fitting models to a large data set obtained from primary H3N2 IAV infection of 340 mice. Prior to a detectable virus-specific immune response (before day 5), the estimated half-life of infected epithelial cells is approximately 1.2 days, and the half-life of free infectious IAV is approximately 4 h. During the adaptive immune response (after day 5), the average half-life of infected epithelial cells is approximately 0.5 days, and the average half-life of free infectious virus is approximately 1.8 min. During the adaptive phase, model fitting confirms that CD8(+) CTLs are crucial for limiting infected cells, while virus-specific IgM regulates free IAV levels. This may imply that CD4 T cells and class-switched IgG antibodies are more relevant for generating IAV-specific memory and preventing future infection via a more rapid secondary immune response. Also, simulation studies were performed to understand the relative contributions of biological parameters to IAV clearance. This study provides a basis to better understand and predict influenza virus immunity.
authors.affiliation: Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York 146421, USA.
authors.forename: Hongyu
authors.initials: H
authors.lastname: Miao
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Hollenbaugh
authors.forename: Martin S
authors.initials: MS
authors.lastname: Zand
authors.forename: Jeanne
authors.initials: J
authors.lastname: Holden-Wiltse
authors.forename: Tim R
authors.initials: TR
authors.lastname: Mosmann
authors.forename: Alan S
authors.initials: AS
authors.lastname: Perelson
authors.forename: Hulin
authors.initials: H
authors.lastname: Wu
authors.forename: David J
authors.initials: DJ
authors.lastname: Topham
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D004847:Epithelial Cells / Q000502:physiology / Q000821:virology; D006207:Half-Life; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008962:Models, Theoretical; D009976:Orthomyxoviridae Infections / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D013997:Time Factors
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M
references.citation: J Immunol. 1997 Dec 1;159(11):5197-200
references.pmid: 9548456
references.citation: PLoS Comput Biol. 2007 Dec;3(12):e240
references.pmid: 18069885
references.citation: Infect Immun. 1979 Sep;25(3):992-7
references.pmid: 500197
references.citation: Nature. 1995 Jan 12;373(6510):123-6
references.pmid: 7816094
references.citation: J Immunol. 1992 Aug 15;149(4):1319-25
references.pmid: 1354233
references.citation: J Theor Biol. 2007 May 7;246(1):70-86
references.pmid: 17266989
references.citation: J Exp Med. 2005 Apr 4;201(7):1101-12
references.pmid: 15795235
references.citation: J Virol. 2004 Apr;78(7):3572-7
references.pmid: 15016880
references.citation: SIAM Rev Soc Ind Appl Math. 2011 Jan 1;53(1):3-39
references.pmid: 21785515
references.citation: Semin Immunol. 2004 Jun;16(3):171-7
references.pmid: 15130501
references.citation: Am J Pathol. 2001 Dec;159(6):2055-69
references.pmid: 11733356
references.citation: PLoS One. 2007 Dec 12;2(12):e1301
references.pmid: 18074025
references.citation: J Exp Med. 2003 Oct 6;198(7):1011-21
references.pmid: 14517272
references.citation: J Virol. 2009 Jul;83(14):7151-65
references.pmid: 19439465
references.citation: J Theor Biol. 1994 Apr 21;167(4):323-60
references.pmid: 7516024
references.citation: Biotechnol Bioeng. 2005 Apr 5;90(1):46-58
references.pmid: 15736163
references.citation: Am J Pathol. 2006 Apr;168(4):1169-78; quiz 1404-5
references.pmid: 16565492
references.citation: Virology. 1997 Dec 8;239(1):217-25
references.pmid: 9426461
references.citation: Ann Appl Stat. 2010 Mar 1;4(1):460-483
references.pmid: 20556240
references.citation: Immunol Rev. 1997 Oct;159:105-17
references.pmid: 9416506
references.citation: J Immunol. 2004 Mar 1;172(5):2731-8
references.pmid: 14978070
references.citation: J Virol. 1996 Feb;70(2):1288-91
references.pmid: 8551597
references.citation: J Virol. 1995 Apr;69(4):2075-81
references.pmid: 7884853
references.citation: J Theor Biol. 2000 Apr 7;203(3):285-301
references.pmid: 10716909
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L231-4
references.pmid: 18487354
references.citation: J Immunol. 1994 Aug 1;153(3):1246-53
references.pmid: 8027552
references.citation: J Immunol. 1996 Oct 1;157(7):2947-52
references.pmid: 8816401
references.citation: J Virol. 1995 Mar;69(3):1429-34
references.pmid: 7853474
references.citation: J Immunol. 1990 May 15;144(10):3980-6
references.pmid: 1692070
references.citation: Nature. 1995 Jan 12;373(6510):117-22
references.pmid: 7529365
references.citation: J Exp Med. 2002 Oct 7;196(7):957-68
references.pmid: 12370257
references.citation: J Immunol. 2009 Sep 1;183(5):3177-87
references.pmid: 19675172
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1599-603
references.pmid: 17242364
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11029-33
references.pmid: 8248207
references.citation: Immunol Cell Biol. 2007 Jun;85(4):274-9
references.pmid: 17420769
references.citation: Nature. 1997 May 8;387(6629):188-91
references.pmid: 9144290
references.citation: Science. 1996 Mar 15;271(5255):1582-6
references.pmid: 8599114
references.citation: Virus Res. 2001 Sep;77(1):3-17
references.pmid: 11451482
references.citation: J Exp Med. 2000 Jul 17;192(2):271-80
references.pmid: 10899913
references.citation: J R Soc Interface. 2009 May 6;6(34):447-54
references.pmid: 18708323
references.citation: Nat Rev Immunol. 2002 Jan;2(1):28-36
references.pmid: 11905835
references.citation: BMC Bioinformatics. 2006 Nov 02;7:483
references.pmid: 17081289
references.citation: J Immunol. 2000 Mar 1;164(5):2635-43
references.pmid: 10679103
references.citation: Ann Stat. 2010 Jan 1;38(4):2351-2387
references.pmid: 21132064
references.citation: J Am Stat Assoc. 2008 Dec 1;103(484):1570-1583
references.pmid: 19956350
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8091-6
references.pmid: 18523003
references.citation: J Exp Med. 1997 Dec 15;186(12):2063-8
references.pmid: 9396777
references.citation: J Virol. 2006 Aug;80(15):7590-9
references.pmid: 16840338
references.citation: J Virol. 2008 Dec;82(23):11749-57
references.pmid: 18815293
references.citation: J Immunol. 2005 Nov 1;175(9):5827-38
references.pmid: 16237075
references.citation: Am J Physiol. 1993 Feb;264(2 Pt 1):L183-92
references.pmid: 8447430
references.citation: J Theor Biol. 2005 Jan 21;232(2):223-34
references.pmid: 15530492
references.citation: J Immunol. 1952 Aug;69(2):155-81
references.pmid: 14946411
references.citation: J Immunol. 1995 Sep 15;155(6):2955-9
references.pmid: 7673713
references.citation: J Math Biol. 2010 May;60(5):711-26
references.pmid: 19633852
references.citation: J Exp Med. 1991 Oct 1;174(4):875-80
references.pmid: 1919440